{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:19:30Z","timestamp":1761819570101,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.prro.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T01:51:06Z","timestamp":1317261066000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation"],"prefix":"10.1016","volume":"2","author":[{"given":"Amar U.","family":"Kishan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Loffredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clair J.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Peter F.","family":"Orio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Kantoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony V.","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2011.08.002_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2011.08.002_bb0010","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2011.08.002_bb0015","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer","volume":"26","author":"Horwitz","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.01.018","article-title":"Short-term endocrine therapy prior to and during radiation therapy improves overall survival in patients with T1b-T2b adenocarcinoma of the prostate and PSA \u226420: Initial results of RTOG 94-08","volume":"77","author":"McGowan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-5347(17)62141-4","article-title":"Breast radiation in patients with carcinoma of the prostate","volume":"102","author":"Malis","year":"1969","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1743-6109.2008.01053.x","article-title":"The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management","volume":"6","author":"Wassersug","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.prro.2011.08.002_bb0035","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1470-2045(05)70464-2","article-title":"Management of gynaecomastia in patients with prostate cancer: A systematic review","volume":"6","author":"Di Lorenzo","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MOU.0b013e32832a082c","article-title":"Complications of androgen deprivation therapy in prostate cancer","volume":"19","author":"Schwandt","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/07357909509024902","article-title":"Preservation of function in genitourinary cancers: Psychosexual and psychosocial issues","volume":"13","author":"Ofman","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1016\/j.prro.2011.08.002_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","article-title":"Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3","volume":"61","author":"Widmark","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.prro.2011.08.002_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia","volume":"60","author":"Tyrrell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","article-title":"Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: A randomised controlled trial","volume":"6","author":"Perdon\u00e0","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.juro.2010.03.137","article-title":"Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and\/or breast pain?","volume":"184","author":"Ozen","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1470-2045(03)00958-6","article-title":"The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy","volume":"4","author":"Dicker","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1748-717X-3-2","article-title":"Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?","volume":"3","author":"Nieder","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0302-2838(02)00435-9","article-title":"Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: Updated results of a multicentric trial","volume":"42","author":"Boccardo","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.pcan.4500782","article-title":"Prevention and management of bicalutamide-induced gynecomastia and breast pain: Randomized endocrinologic and clinical studies with tamoxifen and anastrozole","volume":"8","author":"Saltzstein","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prro.2011.08.002_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","article-title":"Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer","volume":"47","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2005.12.013","article-title":"Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(06)00495-2","article-title":"The bicalutamide 150 mg early prostate cancer program: Findings of the North American trial at 7.7-year median followup","volume":"176","author":"McLeod","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2007.01.031","article-title":"Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: A randomised, placebo-controlled, dose-response study","volume":"52","author":"Fradet","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJM198908173210702","article-title":"A controlled trial of leuprolide with and without flutamide in prostatic carcinoma","volume":"321","author":"Crawford","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2011.08.002_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000474215","article-title":"Tolerability and safety of flutamide in monotherapy, with orchiectomy or with LHRH-a in advanced prostate cancer patients. A Belgian multicenter study of 905 patients","volume":"30","author":"Oosterlinck","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000019546","article-title":"Maximal androgen blockade: Final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center","volume":"33","author":"Denis","year":"1998","journal-title":"Eur Urol"},{"year":"2003","series-title":"Survival analysis","author":"Klein","key":"10.1016\/j.prro.2011.08.002_bb0125"},{"year":"2002","series-title":"Categorical data analysis","author":"Agresti","key":"10.1016\/j.prro.2011.08.002_bb0130"},{"year":"1999","series-title":"Nonparametric statistical methods","author":"Hollander","key":"10.1016\/j.prro.2011.08.002_bb0135"},{"key":"10.1016\/j.prro.2011.08.002_bb0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1464-410X.1991.tb15195.x","article-title":"Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma","volume":"67","author":"Kaisary","year":"1991","journal-title":"Br J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0022-5347(17)38080-1","article-title":"A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group","volume":"146","author":"Tyrrell","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0090-4295(98)00004-1","article-title":"Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: Results from two multicenter randomized trials at a median follow-up of 4 years","volume":"51","author":"Iversen","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.prro.2011.08.002_bb0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2011.08.002_bb0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5347(17)56713-0","article-title":"Pre-estrogen breast irradiation for patients with carcinoma of the prostate: A critical review","volume":"121","author":"Gagnon","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0165","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2004.07.708","article-title":"Coronary heart disease after radiotherapy for peptic ulcer disease","volume":"61","author":"Carr","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2006.08.071","article-title":"Radiation-induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiologic data?","volume":"67","author":"Schultz-Hector","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.1987.35","article-title":"Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis","volume":"55","author":"Darby","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2011.08.002_bb0180","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ijrobp.2007.04.042","article-title":"Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: The role of irradiated heart volume","volume":"69","author":"Borger","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/bjc.1995.461","article-title":"Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease","volume":"72","author":"Mattsson","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2011.08.002_bb0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(196809)22:3<581::AID-CNCR2820220314>3.0.CO;2-N","article-title":"Carcinoma of the male breast following radiation. Report of a case occurring 35 years after radiation therapy of unilateral prepubertal gynecomastia","volume":"22","author":"Lowell","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2011.08.002_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2307\/3577890","article-title":"Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts","volume":"125","author":"Boice","year":"1991","journal-title":"Radiat Res"},{"key":"10.1016\/j.prro.2011.08.002_bb0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jnci\/77.3.689","article-title":"Breast cancer among women given X-ray therapy for acute postpartum mastitis","volume":"77","author":"Shore","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2011.08.002_bb0205","first-page":"9","article-title":"Ionizing radiation and breast cancer in men (United States)","volume":"5","author":"Thomas","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.prro.2011.08.002_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0360-3016(86)90359-7","article-title":"Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: A study of late sequela","volume":"12","author":"Fass","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0215","first-page":"145","article-title":"Gynecomastia\u2014evaluation and current treatment options","volume":"7","author":"Johnson","year":"2011","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.prro.2011.08.002_bb0220","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-5347(17)63684-X","article-title":"The effect of roentgen ray treatment of gynecomastia in patients with prostatic carcinoma treated with estrogenic hormones: A preliminary communication","volume":"94","author":"Alfthan","year":"1965","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0225","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0360-3016(88)90321-5","article-title":"Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy","volume":"15","author":"Chou","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2011.08.002_bb0230","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0090-4295(97)00457-3","article-title":"Tamoxifen for flutamide\/finasteride-induced gynecomastia","volume":"50","author":"Staiman","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.prro.2011.08.002_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/erc.0.0060315","article-title":"Aromatase and gynecomastia","volume":"6","author":"Braunstein","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.prro.2011.08.002_bb0240","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/030089160409000409","article-title":"Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options","volume":"90","author":"Prezioso","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.prro.2011.08.002_bb0245","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1200\/JCO.2005.03.8505","article-title":"Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer","volume":"24","author":"Nakabayashi","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2011.08.002_bb0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.prro.2011.08.002_bb0255","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Urology"},{"issue":"5 Pt 1","key":"10.1016\/j.prro.2011.08.002_bb0260","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","article-title":"Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: Results from the second analysis of the early prostate cancer program at median followup of 5.4 years","volume":"172","author":"Wirth","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2011.08.002_bb0265","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2009.05.019","article-title":"An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients","volume":"57","author":"Bedognetti","year":"2010","journal-title":"Eur Urol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850011002669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850011002669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:16:49Z","timestamp":1761819409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850011002669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1879850011002669"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2011.08.002","relation":{},"ISSN":["1879-8500"],"issn-type":[{"type":"print","value":"1879-8500"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2011.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}